These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 26380917)

  • 1. IGFBP-1 predicts all-cause mortality in elderly women independently of IGF-I.
    Nolte AA; Movin M; Lundin H; Salminen H
    Growth Horm IGF Res; 2015 Dec; 25(6):281-5. PubMed ID: 26380917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke.
    Kaplan RC; McGinn AP; Pollak MN; Kuller LH; Strickler HD; Rohan TE; Cappola AR; Xue X; Psaty BM
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1319-25. PubMed ID: 17264182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations.
    Friedrich N; Haring R; Nauck M; Lüdemann J; Rosskopf D; Spilcke-Liss E; Felix SB; Dörr M; Brabant G; Völzke H; Wallaschofski H
    J Clin Endocrinol Metab; 2009 May; 94(5):1732-9. PubMed ID: 19223521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Serum Insulin-Like Growth Factor-Binding Protein 1 (IGFBP-1) is Associated with High Fracture Risk Independent of Insulin-Like Growth Factor 1 (IGF-I).
    Lundin H; Sääf M; Strender LE; Nyren S; Johansson SE; Salminen H
    Calcif Tissue Int; 2016 Oct; 99(4):333-9. PubMed ID: 27215930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults.
    Kaplan RC; McGinn AP; Pollak MN; Kuller L; Strickler HD; Rohan TE; Xue X; Kritchevsky SB; Newman AB; Psaty BM
    J Am Geriatr Soc; 2008 Apr; 56(4):652-60. PubMed ID: 18312313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study.
    Laughlin GA; Barrett-Connor E; Criqui MH; Kritz-Silverstein D
    J Clin Endocrinol Metab; 2004 Jan; 89(1):114-20. PubMed ID: 14715837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
    Baglietto L; English DR; Hopper JL; Morris HA; Tilley WD; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):763-8. PubMed ID: 17416768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proinsulin and IGFBP-1 predicts mortality in an elderly population.
    Chisalita SI; Dahlström U; Arnqvist HJ; Alehagen U
    Int J Cardiol; 2014 Jun; 174(2):260-7. PubMed ID: 24794551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum insulin-like growth factor-1 binding proteins 1 and 2 and mortality in older adults: the Health, Aging, and Body Composition Study.
    Hu D; Pawlikowska L; Kanaya A; Hsueh WC; Colbert L; Newman AB; Satterfield S; Rosen C; Cummings SR; Harris TB; Ziv E;
    J Am Geriatr Soc; 2009 Jul; 57(7):1213-8. PubMed ID: 19558480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like Growth Factor-1 and IGF Binding Proteins Predict All-Cause Mortality and Morbidity in Older Adults.
    Zhang WB; Aleksic S; Gao T; Weiss EF; Demetriou E; Verghese J; Holtzer R; Barzilai N; Milman S
    Cells; 2020 Jun; 9(6):. PubMed ID: 32492897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
    Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
    Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum insulin-like growth factor (IGF)-I and IGF-binding protein-1 in elderly people: relationships with cardiovascular risk factors, body composition, size at birth, and childhood growth.
    Kajantie E; Fall CH; Seppälä M; Koistinen R; Dunkel L; Ylihärsilä H; Osmond C; Andersson S; Barker DJ; Forsén T; Holt RI; Phillips DI; Eriksson J
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1059-65. PubMed ID: 12629086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of insulin-like growth factor and insulin-like growth factor binding protein-3 with mortality in women with breast cancer.
    Duggan C; Wang CY; Neuhouser ML; Xiao L; Smith AW; Reding KW; Baumgartner RN; Baumgartner KB; Bernstein L; Ballard-Barbash R; McTiernan A
    Int J Cancer; 2013 Mar; 132(5):1191-200. PubMed ID: 22847383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3 and second breast cancer risk in a prevention trial of fenretinide.
    Decensi A; Veronesi U; Miceli R; Johansson H; Mariani L; Camerini T; Di Mauro MG; Cavadini E; De Palo G; Costa A; Perloff M; Malone WF; Formelli F
    Clin Cancer Res; 2003 Oct; 9(13):4722-9. PubMed ID: 14581342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low levels of insulin-like growth-factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): the Söderåkra Cardiovascular Risk Factor Study.
    Petersson U; Ostgren CJ; Brudin L; Brismar K; Nilsson PM
    Diabetes Metab; 2009 Jun; 35(3):198-205. PubMed ID: 19297224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer.
    Severi G; Morris HA; MacInnis RJ; English DR; Tilley WD; Hopper JL; Boyle P; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1137-41. PubMed ID: 16775172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
    Heald A; Kaushal K; Anderson S; Redpath M; Durrington PN; Selby PL; Gibson MJ
    Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of insulin-like growth factor-I, IGF-binding proteins-1, -2 and -3 and lung cancer risk in women.
    Lukanova A; Toniolo P; Akhmedkhanov A; Biessy C; Haley NJ; Shore RE; Riboli E; Rinaldi S; Kaaks R
    Int J Cancer; 2001 Jun; 92(6):888-92. PubMed ID: 11351312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
    Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K
    Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.